Registration and lunch
Registrations and a light lunch to settle into the conference and connect with fellow participants
Registrations and a light lunch to settle into the conference and connect with fellow participants
MCs welcome participants and set the tone for the day ahead
Details to be announced soon — stay tuned!
While drawing lessons from the COVID-19 pandemic, the aim of the session will be on shaping a forward-looking approach to strengthen Europe’s ability to respond effectively to future health crises without compromising patient safety and continuity of care. The discussion will also focus on recent strategies such as the European Preparedness Union Strategy and the Strategy to support development and procurement of medical countermeasures against public health threats.
With:
Dr Ole Johan Bakke, President, Standing Committee of European Doctors (CPME)
Marko Korenjak, President, European Liver Patient Association (ELPA)
Dr Karine Lacombe, Coordinator, Project 'A European Proactive Adaptive Clinical Trials Network within EU-Responses' (PROACT EU-Response)
Oxana Domenti, Representative to the European Union, World Health Organisation (WHO)
Connect and network with peers
Three workshops will be held simunltaneously, please find all details below.
Workshop 1 - AMR preparedness: how healthcare systems and patient organisations can work together
Most players in the healthcare sector are now well aware of the threats posed by antimicrobial resistance. Thus, this session shifts the focus from problem to action. Each speaker will spotlight one of the key solutions to the problem of antimicrobial resistance.
With:
Dr Ulrica Dohnhammar, Coordinator, Project 'European partnership on One Health Antimicrobial Resistance' (EUP OHAMR)
Danilo Lo Fo Wong, Regional Adviser Control of Antimicrobial Resistance, World Health Organisation (WHO)
Borislava Ananieva, Capacity Building Officer and Patient Advocate, European Patients' Forum (EPF)
Workshop 2 - Healthcare delivery, public health, patient care, and the environment: a solvable equation?
Details to be announced soon — stay tuned!
Workshop 3 - Health and wealth: can the EU budget drive a resilient future?
This session invites key stakeholders to explore how health can remain a priority in the next Multiannual Financial Framework (MFF) — and how to ensure it is properly reflected in future EU funding. At a time when geopolitical challenges dominate the narrative, participants will reflect on the need to rethink our narrative to maintain health high on the EU agenda.
With:
Florence Berteletti, Secretary General, The European Alcohol Policy Alliance (Eurocare)
Marie Morfouace, Project Lead, Project 'Integrated iMMUnoprofiling of large adaptive CANcer patient cohorts' (IMMUcan)
Loredana Simulescu, Executive Director, Biomedical Alliance in Europe
Details to be announced soon — stay tuned!
Wrap-up of the day’s highlights and a look ahead to what’s coming on Day 2
Unwind from Day 1 and network over drinks with fellow participants
Enjoy great conversations and make new connections over a relaxed, sit-down dinner
Registrations and a warm drink to settle into the conference and connect with fellow participants
MCs welcome participants and set the tone for the day ahead
While digital innovation and Artificial Intelligence (AI) promise to revolutionise health systems by improving diagnostics, workflows, and access to care, they also raise critical questions about human oversight, trust, and the preservation of empathy in an increasingly automated environment. This session will explore how digital and AI technologies can support more human-centred healthcare systems and how the European Health Data Space (EHDS) can drive responsible innovation, and reinforce patient agency.
With:
Donna Henderson, Head of International Engagement, Scottish Government, Digital Health and Care Directorate, International Engagement Team
Marco Marsella, Director for Digital, EU4Health and Health Systems modernization, European Commission, Directorate-General for Health and Food Safety (DG SANTE)
Bogi Eliasen, Director of Health, Copenhagen Institute for Futures Studies
Tomáš Doležal, Chair, Council of Europe, Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)
Lara Bloom, Chief Executive Officer, Ehlers-Danos
Connect and network with peers
Three workshops will be held simunltaneously, please find all details below.
Workshop 4 - No one left behind: equity and solidarity in cross-border crisis response
Despite collective efforts, the needs of underrepresented and underserved patients are often overlooked. Patients face barriers including inadequate outreach to marginalised communities, inequitable access to clinical trials and inflexible study designs. This session will explore how principles of equity and solidarity can drive inclusive and effective access to clinical studies in cross-border crisis responses.
With:
Maria Dutarte, Executive Director, European Patients' Academy on Therapeutic Innovation (EUPATI)
Melanie Hoste, Postdoctoral Researcher, University of Antwerp
Pauline Delahaye, Researcher, Vaccination et Lien Social (VLS)
Workshop 5 - Value in crisis: rethinking what matters in health
Healthcare systems are stretched by rising demand, workforce shortages, inflationary pressures, and technological acceleration. Traditional concepts of value, focused mainly on cost-effectiveness and clinical outcomes, are no longer sufficient. This session will make the case for a broader, more inclusive definition of value, one that reflects public health priorities, societal resilience, equity, and the lived experiences of patients.
With:
Workshop 6 - Addressing access needs through innovative models for pricing and reimbursement
Traditional pricing and reimbursement (P&R) models are facing mounting pressure amid rising public expectations and tightening healthcare budgets. This session will explore how innovative P&R approaches can help ensure that breakthrough health technologies are made accessible in a way that is timely, affordable, and equitable across Europe.
With:
Carin uyl de Groot, Professor of Health Technology Assessment, Erasmus University Rotterdam
Pedro Facon, Deputy Chief Executive Officer, Institut national d'assurance maladie-invalidité (RIZIV-INAMI)
Valérie Paris, Senior Economist and Health Policy Analyst, Organisation for Economic Co-operation and Development (OECD)
Take a break and enjoy a light lunch
In a year marked by discussions on the Pharmaceuticals Reform, the European Biotech Act, and the Critical Medicines Act, this session will explore how to holistically involve patients and patient organisations across the entire life sciences ecosystem, from clinical trials and regulatory decisions to health technology assessment and patient experience data.
With:
Steffen Thirstrup, Chief Medical Officer, European Medicines Agency (EMA)
Monica Otto, Associate Professor of Practice Health Policy, SDA Bocconi School of Management
Marco Greco, President, European Patients’ Forum (EPF)
Wrap-up to reflect on key moments from the event and thank all who made it possible
More information coming soon.